Humacyte was initially published as one of our 7investing Community's New Ideas in August 2024

Discuss Humacyte in our Community Forum

Background

The following comes directly from our initial Community recommendation. 7investing's opinions may differ from the person(s) who submitted this community research.

Humacyte (HUMA) has developed a shelf-stable artery that, although just waiting on PDUFA approval 8/10/24 for trauma, will, over time revolutionize the way vascular grafts are performed.

In time, these grafts will be preferred over harvested for nearly all vascular conditions as well as AV fistulas in end-stage-renal-disease.

There is no competition.